BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25442981)

  • 1. The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice.
    De Cock E; Hermans C; De Raeymaecker J; De Ceunynck K; De Maeyer B; Vandeputte N; Vandenbulcke A; Deckmyn H; Rottensteiner H; De Maeyer M; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2015 Feb; 13(2):283-92. PubMed ID: 25442981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
    Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
    Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.
    Camilleri RS; Cohen H; Mackie IJ; Scully M; Starke RD; Crawley JT; Lane DA; Machin SJ
    J Thromb Haemost; 2008 Feb; 6(2):331-8. PubMed ID: 18031293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura.
    Uchida T; Wada H; Mizutani M; Iwashita M; Ishihara H; Shibano T; Suzuki M; Matsubara Y; Soejima K; Matsumoto M; Fujimura Y; Ikeda Y; Murata M;
    Blood; 2004 Oct; 104(7):2081-3. PubMed ID: 15126318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of ADAMTS13 missense mutation R1060W in adult Egyptian patients with thrombotic thrombocytopenic purpura.
    El Sissy MH; El Hafez AA; El Sissy AH
    Acta Haematol; 2014; 132(1):30-5. PubMed ID: 24401653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura.
    Donadelli R; Banterla F; Galbusera M; Capoferri C; Bucchioni S; Gastoldi S; Nosari S; Monteferrante G; Ruggeri ZM; Bresin E; Scheiflinger F; Rossi E; Martinez C; Coppo R; Remuzzi G; Noris M;
    Thromb Haemost; 2006 Oct; 96(4):454-64. PubMed ID: 17003922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Veyradier A; Lavergne JM; Ribba AS; Obert B; Loirat C; Meyer D; Girma JP
    J Thromb Haemost; 2004 Mar; 2(3):424-9. PubMed ID: 15009458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom.
    Camilleri RS; Scully M; Thomas M; Mackie IJ; Liesner R; Chen WJ; Manns K; Machin SJ
    J Thromb Haemost; 2012 Sep; 10(9):1792-801. PubMed ID: 22783805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity.
    Savasan S; Lee SK; Ginsburg D; Tsai HM
    Blood; 2003 Jun; 101(11):4449-51. PubMed ID: 12576319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel homozygous missense ADAMTS13 mutation Y658C in a patient with recurrent thrombotic thrombocytopenic purpura.
    Lee SH; Park JH; Park SK; Lee EH; Choi JI; Visentin GP; Park TS; Oh SH; Kim SR
    Ann Clin Lab Sci; 2011; 41(3):273-6. PubMed ID: 22075512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Hommais A; Rayes J; Houllier A; Obert B; Legendre P; Veyradier A; Girma JP; Ribba AS
    Thromb Haemost; 2007 Sep; 98(3):593-9. PubMed ID: 17849048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
    Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy.
    Verhenne S; Vandeputte N; Pareyn I; Izsvák Z; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):836-844. PubMed ID: 28254814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset congenital thrombotic thrombocytopenic purpura caused by a novel compound heterozygous mutation of the ADAMTS13 gene.
    Krabbe JG; Kemna EW; Strunk AL; Jobse PA; Kramer PA; Dikkeschei LD; van den Heuvel LP; Fijnheer R; Verdonck LF
    Int J Hematol; 2015 Oct; 102(4):477-81. PubMed ID: 26267233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.
    Schiviz A; Wuersch K; Piskernik C; Dietrich B; Hoellriegl W; Rottensteiner H; Scheiflinger F; Schwarz HP; Muchitsch EM
    Blood; 2012 Jun; 119(25):6128-35. PubMed ID: 22529289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
    Rank CU; Kremer Hovinga J; Taleghani MM; Lämmle B; Gøtze JP; Nielsen OJ
    Eur J Haematol; 2014 Feb; 92(2):168-71. PubMed ID: 24033710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.